Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective Since the inflammatory process has been implicated in the pathophysiology of psychiatric disorder, an important issue emerging is to assess the test-retest reliability of cytokine measurement in healthy individuals and patients with schizophrenia. The objective of the present study was to investigate the test-retest reliability of bead-based multiplex immunoassay technology (BMIT) for cytokine measurement by using a Bland-Altman plot (BAP). Methods Twenty healthy individuals and twenty patients with schizophrenia were enrolled, and a 17-plex cytokine assay was used to measure inflammatory biomarkers at baseline and two weeks later. The test-retest reliability was examined by BAP, 95% limits of agreement (LOA), intraclass correlation coefficient (ICC), and coefficient of repeatability (CoR). Results In the healthy controls, only interleukin (IL)-2, IL-13, IL-10, IL-17, and macrophage inflammatory protein-1β showed excellent ICC. The BAP with 95% LOA determined that 13 cytokines showed acceptable 95% LOA for a 2-week test-retest reliability, and only IL-1β, IL-12 and tumor necrosis factor (TNF)-α had significant test-retest bias. The CoR of cytokines varied significantly, ranging from 1.72 to 218.1. Compared with healthy controls, patients with schizophrenia showed significantly higher levels of IL-5, IL-13, and TNF-α and significantly lower levels of IL-4, IL-12, and interferon-gamma (IFN-γ). Of these six cytokines, IL-12 and TNF-α were considered suboptimal reliability. Conclusion The findings from ICC and CoR implied that the test-retest reliability of BMIT for cytokine measurement were suboptimal. However, the BAP with 95% LOA confirmed that BMIT can reliably distinguish schizophrenia from healthy individuals in cytokine measurement, while significant within-subject variation and between-group overlapping were evident in cytokine expression.
Abstract
Objective Since the inflammatory process has been implicated in the pathophysiology of psychiatric disorder, an important issue emerging is to assess the test-retest reliability of cytokine measurement in healthy individuals and patients with schizophrenia. The objective of the present study was to investigate the test-retest reliability of bead-based multiplex immunoassay technology (BMIT) for cytokine measurement by using a Bland-Altman plot (BAP). Methods Twenty healthy individuals and twenty patients with schizophrenia were enrolled, and a 17-plex cytokine assay was used to measure inflammatory biomarkers at baseline and two weeks later. The test-retest reliability was examined by BAP, 95% limits of agreement (LOA), intraclass correlation coefficient (ICC), and coefficient of repeatability (CoR). Results In the healthy controls, only interleukin (IL)-2, IL-13, IL-10, IL-17, and macrophage inflammatory protein-1β showed excellent ICC. The BAP with 95% LOA determined that 13 cytokines showed acceptable 95% LOA for a 2-week test-retest reliability, and only IL-1β, IL-12 and tumor necrosis factor (TNF)-α had significant test-retest bias. The CoR of cytokines varied significantly, ranging from 1.72 to 218.1. Compared with healthy controls, patients with schizophrenia showed significantly higher levels of IL-5, IL-13, and TNF-α and significantly lower levels of IL-4, IL-12, and interferon-gamma (IFN-γ). Of these six cytokines, IL-12 and TNF-α were considered suboptimal reliability. Conclusion The findings from ICC and CoR implied that the test-retest reliability of BMIT for cytokine measurement were suboptimal. However, the BAP with 95% LOA confirmed that BMIT can reliably distinguish schizophrenia from healthy individuals in cytokine measurement, while significant within-subject variation and between-group overlapping were evident in cytokine expression.
참고문헌 (33)
- Khandaker GM, "Inflammation and immunity in schizophrenia : implications for pathophysiology and treatment", Lancet Psychiatry, 2, pp.258~270 (2015)
- Potvin S, "Inflammatory cytokine alterations in schizophrenia : a systematic quantitative review", Biol Psychiatry, 63, pp.801~808 (2008)
- Watanabe Y, "Cytokine hypothesis of schizophrenia pathogenesis : evidence from human studies and animal models", Psychiatry Clin Neurosci, 64, pp.217~230 (2010)
- Che-Sheng Chu, "Decreased IL-1ra and NCAM-1", CD56 Serum Levels in Unmedicated Patients with Schizophrenia Before and After Antipsychotic Treatment, 2018, pp.15(7), 727~732[DOI]
- Buka SL, "Maternal infections and subsequent psychosis among offspring", Arch Gen Psychiatry, 58, pp.1032~1037 (2001)
- Mortensen PB, "Toxoplasma gondii as a risk factor for earlyonset schizophrenia : analysis of filter paper blood samples obtained at birth", Biol Psychiatry, 61, pp.688~693 (2007)
- Nielsen PR, "Neonatal levels of inflammatory markers and later risk of schizophrenia", Biol Psychiatry, 77, pp.548~555 (2015)
- Miller BJ, "Meta-analysis of cytokine alterations in schizophrenia : clinical status and antipsychotic effects", Biol Psychiatry, 70, pp.663~671 (2011)
- Bevan-Jones WR, "Neuroimaging of Inflammation in Memory and Related Other Disorders(NIMROD)study protocol : a deep phenotyping cohort study of the role of brain inflammation in dementia, depression and other neurological illnesses", BMJ Open, 7, pp.e013187~ (2017)
- Roiz-Santianez R, "Interleukin-1 receptor antagonist genotype and brain morphometry in first-episode non-affective psychosis", Psychiatry Res, 162, pp.167~171 (2008)
- Shenton ME, "A review of MRI findings in schizophrenia", Schizophr Res, 49, pp.1~52 (2001)
- Barch DM, "Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia", Arch Gen Psychiatry, 58, pp.280~288 (2001)
- Glahn DC, "Beyond hypofrontality : a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia", Hum Brain Mapp, 25, pp.60~69 (2005)
- Chowdhury F, "Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling", J Immunol Methods, 340, pp.55~64 (2009)
- Müller N, "Immune system and schizophrenia", Curr Immunol Rev, 6, pp.213~220 (2010)
- Berchtold A, "Test-retest: agreement or reliability?", Method Innov, 9, pp.1~7 (2016)
- Ho PS, "Limitations of measuring blood cytokines in biological psychiatry", Psychoneuroendocrinology, 78, pp.253~ (2017)
- Myles PS, "Using the Bland-Altman method to measure agreement with repeated measures", Br J Anaesth, 99, pp.309~311 (2007)
- American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision, DSM-IV-TR" (2000), American Psychiatric Association
- Larsson A, "The body mass index(BMI)is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid", Cytokine, 76, pp.514~518 (2015)
- Larsson A, "The effects of age and gender on plasma levels of 63 cytokines", J Immunol Methods, 425, pp.58~61 (2015)
- Bartlett JW, "Reliability, repeatability and reproducibility : analysis of measurement errors in continuous variables", Ultrasound Obstet Gynecol, 31, pp.466~475 (2008)
- Gu Y, "Reproducibility of serum cytokines and growth factors", Cytokine, 45, pp.44~49 (2009)
- Belzeaux R, "How to : measuring blood cytokines in biological psychiatry using commercially available multiplex immunoassays", Psychoneuroendocrinology, 75, pp.72~82 (2017)
- Koo TK, "A guideline of selecting and reporting intraclass correlation coefficients for reliability research", J Chiropr Med, 15, pp.155~163 (2016)
- Churchman S, "Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis : lack of sensitivity and interference by rheumatoid factor", Clin Exp Rheumatol, 30, pp.534~542 (2012)
- duPont NC, "Validation and comparison of luminex multiplex cytokine analysis kits with ELISA : determinations of a panel of nine cytokines in clinical sample culture supernatants", J Reprod Immunol, 66, pp.175~191 (2005)
- Goldsmith DR, "A meta-analysis of blood cytokine network alterations in psychiatric patients : comparisons between schizophrenia, bipolar disorder and depression", Mol Psychiatry, 21, pp.1696~1709 (2016)
- O’Brien SM, "Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia", Psychiatry Res, 160, pp.256~262 (2008)
- Altara R, "Diurnal rhythms of serum and plasma cytokine profiles in healthy elderly individuals assessed using membrane based multiplexed immunoassay", J Transl Med, 13, pp.129~ (2015)
- Chaturvedi AK, "Evaluation of multiplexed cytokine and inflammation marker measurements : a methodologic study", Cancer Epidemiol Biomarkers Prev, 20, pp.1902~1911 (2011)
- Rosenberg-Hasson Y, "Effects of serum and plasma matrices on multiplex immunoassays", Immunol Res, 58, pp.224~233 (2014)
- Leng SX, "Elisa and multiplex technologies for measurement in inflammation and aging research", J Gerontol A Biol Sci Med Sci, 63, pp.879~884 (2008)